EA201001592A1 - Гомеопатическое лекарственное средство - Google Patents

Гомеопатическое лекарственное средство

Info

Publication number
EA201001592A1
EA201001592A1 EA201001592A EA201001592A EA201001592A1 EA 201001592 A1 EA201001592 A1 EA 201001592A1 EA 201001592 A EA201001592 A EA 201001592A EA 201001592 A EA201001592 A EA 201001592A EA 201001592 A1 EA201001592 A1 EA 201001592A1
Authority
EA
Eurasian Patent Office
Prior art keywords
homeopathic
neurological diseases
medicinal
treatment
treating
Prior art date
Application number
EA201001592A
Other languages
English (en)
Inventor
Гунвант Девичанд Освал
Пооя Гунвант Освал
Original Assignee
Гунвант Девичанд Освал
Пооя Гунвант Освал
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Гунвант Девичанд Освал, Пооя Гунвант Освал filed Critical Гунвант Девичанд Освал
Publication of EA201001592A1 publication Critical patent/EA201001592A1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Изобретение относится к медицине, в частности к гомеопатическому лекарственному средству для лечения неврологических заболеваний, а также к способу его приготовления. Гомеопатическое средство совместно с физиологически приемлемыми носителями содержит тинктуры и/или смесь гомеопатических препаратов, при этом пропорция каждого ингредиента из одной группы варьируется от 1:1 до 1:10 по отношению к элементу другой группы. Лекарственная форма средства может быть в одной из таких форм, как таблетки, капсулы, порошки, крупинки, леденцы, пилюли, гранулы, растворы, сиропы, эликсиры, суспензии, эмульсии. Данное гомеопатическое средство эффективно при лечении некоторых типов неврологических заболеваний, оно стабильно, не токсично, побочные эффекты при лечении отсутствуют, его просто и легко приготовить, оно может сочетаться с любыми другими гомеопатическими препаратами для достижения желаемого эффекта, оно является общедоступным лекарственным средством для лечения ряда неврологических заболеваний, при этом не требуется практикующаяся в классической гомеопатии лекарственная индивидуализация с назначением единственного лекарственного ингредиента на одну дозу приёма.
EA201001592A 2008-04-29 2009-04-27 Гомеопатическое лекарственное средство EA201001592A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN940MU2008 2008-04-29
PCT/IN2009/000253 WO2009133573A2 (en) 2008-04-29 2009-04-27 A homeopathic formulation

Publications (1)

Publication Number Publication Date
EA201001592A1 true EA201001592A1 (ru) 2011-08-30

Family

ID=54253313

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201001592A EA201001592A1 (ru) 2008-04-29 2009-04-27 Гомеопатическое лекарственное средство

Country Status (15)

Country Link
US (1) US20110038949A1 (ru)
EP (1) EP2296681A4 (ru)
JP (2) JP2011518876A (ru)
KR (1) KR101321031B1 (ru)
CN (1) CN102014939A (ru)
AU (1) AU2009241221B2 (ru)
BR (1) BRPI0912026A2 (ru)
CA (1) CA2722121A1 (ru)
CH (1) CH701268B1 (ru)
EA (1) EA201001592A1 (ru)
IL (1) IL208902A (ru)
MX (1) MX339704B (ru)
MY (1) MY161415A (ru)
SG (1) SG190594A1 (ru)
WO (1) WO2009133573A2 (ru)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0917684A2 (pt) * 2008-08-29 2015-12-01 Nancy Josephine Polich método terapêutico homeopático
WO2011085307A1 (en) * 2010-01-11 2011-07-14 Phoenix Biotechnology, Inc. Method of treating neurological conditions with cardiac glycosides
EP2568958A1 (en) * 2010-05-14 2013-03-20 Deseret Biologicals, Inc. Formulations of diluted genetic material and methods for making same
FR2962909A1 (fr) * 2010-07-21 2012-01-27 Oleg Iliich Epshtein Composition pharmaceutique d'association et son utilisation dans des procedes pour traiter les maladies ou affections associees avec une maladie ou affection respiratoire
US10022335B2 (en) 2011-03-03 2018-07-17 Nancy Josephine Polich Homeopathic therapeutic method and compositions
US9603898B2 (en) 2011-03-23 2017-03-28 Deseret Biologicals, Inc. Formulations of diluted amino acid segments and methods for making same
CN114306171A (zh) * 2011-03-28 2022-04-12 玫琳凯有限公司 局部皮肤用组合物及其用途
US9545429B1 (en) * 2011-09-03 2017-01-17 Biolyte Laboratories, Llc Homeopathic formulations
EP2591823A1 (en) * 2011-11-11 2013-05-15 Biologische Heilmittel Heel GmbH Composition for treating or preventing neurodegenerative disorders
RU2484839C1 (ru) * 2012-02-06 2013-06-20 Михаил Михайлович Шашурин Способ получения экстракта рододендрона золотистого с пониженным содержанием стероидных (сердечных) гликозидов
WO2013138306A1 (en) 2012-03-15 2013-09-19 Princeton Biotechnology Corporation Compositions and methods for treatment of pain
US8551535B1 (en) 2012-08-06 2013-10-08 Sarah McCann Homeopathic remedies and methods for enhancing weight loss
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics
WO2015030567A1 (es) * 2013-08-30 2015-03-05 Zamarripa Blas Juan Alberto Mejoras a formulación auxiliar para contrarrestar efectos adversos de tratamientos contra el cáncer y de tratamientos contra algunas enfermedades víricas
KR101540107B1 (ko) * 2015-02-05 2015-07-30 주식회사 다림바이오텍 반복적 희석 및 진탕을 이용한 경구용 제제의 제조방법
US20170290873A1 (en) * 2016-04-08 2017-10-12 Stellalife Method Of Using Homeopathic Kit Containing Gel, Rinse And Spray For Management Of Post-Oral Surgical Recovery And Maintenance Of Oral Health
US10499584B2 (en) 2016-05-27 2019-12-10 New West Genetics Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles
US10828251B1 (en) 2017-01-14 2020-11-10 Biolyte Laboratories, Llc Homeopathic formulations
US10617634B1 (en) 2017-03-10 2020-04-14 Biolyte Laboratories, Llc Topical homeopathic formulations for menstrual cramps
WO2019104442A1 (en) * 2017-11-30 2019-06-06 Canopy Growth Corporation Liquid dosage forms, methods of making and use
WO2020072850A1 (en) * 2018-10-04 2020-04-09 Stellalife, Inc. Compositions and methods for promoting and maintaining oral health
EP4069215A4 (en) 2019-12-06 2024-01-17 Jlabs Beauty LLC TOPICAL COMPOSITIONS CONTAINING ROSE OIL AND CANNABIDIOL AND METHODS OF PREPARING AND USING THE SAME
KR102273322B1 (ko) * 2020-04-29 2021-07-06 우보한의연구소(주) 복합 한약재 추출물을 유효성분으로 포함하는 알츠하이머병 예방, 치료, 또는 개선용 조성물
RU2746080C1 (ru) * 2020-07-20 2021-04-06 Сергей Анатольевич Небера Гомеопатическое средство для купирования тика век
EP4368172A1 (de) * 2022-11-11 2024-05-15 Gernot A. Overbeck Verfahren zur herstellung eines analogen homöopathischen wirkstoffs, vorrichtung zur durchführung des verfahrens und computerprogrammprodukt

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2073515C1 (ru) * 1993-01-20 1997-02-20 Игорь Электринович Острейковский Способ лечения травматического поражения головного мозга
RU2074714C1 (ru) * 1993-03-11 1997-03-10 Игорь Электринович Острейковский Способ лечения пациентов с поражением центральной нервной системы
US20060088575A1 (en) * 1994-03-31 2006-04-27 Brewitt Barbara A Homeopathic preparations of purified growth factors and purified growth hormones and associated carriers
DE19738903A1 (de) * 1997-09-05 1999-03-11 Reimar Dr Med Banis Stoffe
RU2143275C1 (ru) * 1999-05-06 1999-12-27 Общество с ограниченной ответственностью "Доктор Н" Гомеопатическое лекарственное средство для лечения бессонницы и повышенной нервной возбудимости "валериана-плюс мультигран"
RU2150288C1 (ru) * 1999-10-25 2000-06-10 Небера Сергей Анатольевич Гомеопатическое средство для лечения спазма аккомодации
RU2224526C1 (ru) * 2002-11-04 2004-02-27 Государственное учреждение Научно-исследовательский институт психического здоровья Томского научного центра СО РАМН Средство для профилактики и лечения боевой психической травмы
CA2518965C (en) * 2003-03-14 2018-10-30 Nutrition Research Inc. Homeopathic formulations useful for treating pain and/or inflammmation
US7037532B2 (en) * 2004-03-03 2006-05-02 Innovation Ventures, Llc Hangover relief composition
US20050249763A1 (en) * 2004-04-19 2005-11-10 L'oreal Kit for formulating a cosmetic product
US20060165812A1 (en) * 2005-01-21 2006-07-27 Amershire Investment Corporation Method and topical formulation for treating headaches
US20070275096A1 (en) * 2006-05-19 2007-11-29 Trp, Inc., A Nevada Corporation Composition and methodology for the treatment of hearing impairment symptoms
WO2009047004A1 (en) * 2007-10-10 2009-04-16 Daniel Farrington A homeopathic complex

Also Published As

Publication number Publication date
JP2014062106A (ja) 2014-04-10
CN102014939A (zh) 2011-04-13
US20110038949A1 (en) 2011-02-17
JP5819909B2 (ja) 2015-11-24
EP2296681A4 (en) 2012-04-18
KR20100137013A (ko) 2010-12-29
AU2009241221A1 (en) 2009-11-05
EP2296681A2 (en) 2011-03-23
MY161415A (en) 2017-04-14
CH701268B1 (de) 2012-06-15
WO2009133573A3 (en) 2010-05-06
WO2009133573A2 (en) 2009-11-05
MX2010011715A (es) 2010-12-06
CA2722121A1 (en) 2009-11-05
MX339704B (es) 2016-06-06
KR101321031B1 (ko) 2013-10-23
AU2009241221B2 (en) 2015-02-05
BRPI0912026A2 (pt) 2015-10-06
IL208902A0 (en) 2011-01-31
JP2011518876A (ja) 2011-06-30
SG190594A1 (en) 2013-06-28
IL208902A (en) 2015-09-24

Similar Documents

Publication Publication Date Title
EA201001592A1 (ru) Гомеопатическое лекарственное средство
NI201100194A (es) Derivados de tieno [2, 3 - b] piridina como inhibidores de la replicación viral
MX2010005631A (es) Nuevos compuestos de hidrocarburo ciclicos para el tratamiento de enfermedades.
AU2008215743B2 (en) A composition for selective serotonin reuptake inhibition and process thereof
RU2010150478A (ru) Способы профилактики и лечения нейродегенеративных заболеваний
RU2006101225A (ru) Пероральные лекарственные формы мемантина
RU2011111792A (ru) Применение парацетамола и ибупрофена в лечении
EA201101622A1 (ru) Пептидная фармацевтическая композиция, средство на ее основе для лечения гастродуоденальных заболеваний, вызываемых helicobacter pylori, и способ его использования
JP2010083758A (ja) 抗ウイルス剤
CN101167889A (zh) 一种治疗昏厥、风湿性关节炎的中药
CN101829241B (zh) 一种治疗带状疱疹、黄水疮或急性湿疹的外搽酊剂
CN108837143B (zh) 曲普瑞林的应用
CN101897891A (zh) 一种治疗瘿瘤的中药散剂
CN103749551A (zh) 一种预防感冒的空气消毒剂
RU2245157C2 (ru) Биологически активная добавка для профилактики и лечения гриппа "фитогриппин"
RU2125456C1 (ru) Гомеопатическое лекарственное средство "фарингол-arn"
CN103157077A (zh) 姜枣丸
CN101732418A (zh) 一种治疗糖尿病的中药糊剂
CN101757216A (zh) 一种治疗牙痛的中药
Antoliková et al. ST. JOHN’S WORT MEDICINAL PRODUCTS IN SLOVAKIA–EFFICACY OF ORAL FORMULATION OF SJW PRODUCTS.
CN102125639A (zh) 镇痛药
RU2442599C2 (ru) ГОМЕОПАТИЧЕСКОЕ ЛЕКАРСТВЕННОЕ СРЕДСТВО И БИОЛОГИЧЕСКИ АКТИВНАЯ ДОБАВКА К ПИЩЕ, СОДЕРЖАЩИЕ Nisylen, Сера, Euphrasia, Belladonna И/ИЛИ Mercurius solubilis
CN109908215A (zh) 一种治疗鼻炎的药物组合物及其应用
CN103536875B (zh) 一种治疗少儿牙龈炎的药剂的制备方法
Sahoo et al. Drug toxicity (Aushadha vyapata) in ayurveda